30 September 2024 Pillar 3 Report |
UBS Group | Leverage ratio
12
Off-balance sheet items increased by USD 0.1bn, mainly due to currency effects
of USD 2.0bn, partly offset by asset size
and other movements of USD 1.9bn. The asset size movement
was primarily driven by lower commitments.
›
Refer to “Leverage ratio denominator” in the
“Risk, capital, liquidity and funding, and balance
sheet” section of the UBS Group
third quarter 2024 report,
available under “Quarterly reporting” at
ubs.com/investors
, for more information
LR1: BCBS Basel III leverage ratio summary comparison
USD m
30.9.24
30.6.24
1
Total consolidated assets as per published financial statements
2
Adjustment for investments in banking, financial, insurance or
commercial entities that are consolidated for accounting
purposes but outside the
scope of regulatory consolidation
1,2
3
Adjustment for fiduciary assets recognized on the balance
sheet pursuant to the operative accounting framework but excluded
from the leverage
ratio exposure measure
4
Adjustments for derivative financial instruments
5
Adjustment for securities financing transactions (i.e., repos and similar secured
lending)
6
Adjustment for off-balance sheet items (i.e., conversion to credit equivalent
amounts of off-balance sheet exposures)
7
Other adjustments
7a
of which: Transitional CET1 capital purchase price allocation adjustments
3
7b
of which: consolidated entities under the regulatory scope
of consolidation
2
8
Leverage ratio exposure (leverage ratio denominator)
1 Includes assets that are deducted from tier 1 capital.
2 Row 7b includes entities which are consolidated under the regulatory scope of consolidation, but not under the IFRS scope of consolidation. Reports prior to
this third quarter of 2024
report had also included
exposures related to certain
special purpose vehicles which
had been deconsolidated on
row 2. From
the third quarter of
2024 onwards,
this approach has been
refined, with no bottom-line impact on row 8. Prior
periods have not been restated.
3 In the third quarter of 2024,
we accelerated the amortization of the remaining transitional CET1 capital purchase
price allocation
adjustments. Refer to the “Introduction and basis for preparation” section of this report for more information
about the change in CET1 capital deduction items.
LR2: BCBS Basel III leverage ratio common disclosure
USD m, except where indicated
30.9.24
30.6.24
On-balance sheet exposures
1
On-balance sheet items (excluding derivatives and securities financing
transactions (SFTs), but including collateral)
2
(Asset amounts deducted in determining Basel III Tier 1 capital)
2a
Transitional CET1 capital purchase price allocation adjustments
1
3
Total on-balance sheet exposures (excluding derivatives and SFTs)
Derivative exposures
4
Replacement cost associated with all derivatives transactions (i.e., net of eligible
cash variation margin)
5
Add-on amounts for PFE associated with all derivatives transactions
6
Gross-up for derivatives collateral provided where deducted from
the balance sheet assets pursuant to the operative accounting framework
7
(Deductions of receivables assets for cash variation margin provided
in derivatives transactions)
8
(Exempted QCCP leg of client-cleared trade exposures)
9
Adjusted effective notional amount of all written credit
derivatives
2
10
(Adjusted effective notional offsets and add-on deductions for
written credit derivatives)
3
11
Total derivative exposures
Securities financing transaction exposures
12
Gross SFT assets (with no recognition of netting), after adjusting
for sale accounting transactions
13
(Netted amounts of cash payables and cash receivables of gross SFT assets)
14
CCR exposure for SFT assets
15
Agent transaction exposures
16
Total securities financing transaction exposures
Other off-balance sheet exposures
17
Off-balance sheet exposure at gross notional amount
18
(Adjustments for conversion to credit equivalent amounts)
19
Total off-balance sheet items
Total exposures (leverage ratio denominator)
Capital and total exposures (leverage ratio denominator)
20
Tier 1 capital
21
Total exposures (leverage ratio denominator)
Leverage ratio
22
Basel III leverage ratio (%)
1 In the third quarter of 2024,
we accelerated the amortization of
the remaining transitional CET1 capital
purchase price allocation adjustments.
Refer to the “Introduction and
basis for preparation” section of
this
report for more
information about the
change in CET1
capital deduction items.
2 Includes protection sold,
including agency transactions.
3 Protection sold can
be offset with
protection bought on
the same
underlying reference entity, provided that the conditions according to the Basel III leverage ratio
framework and disclosure requirements are met.